Enhancing Pediatric Sarcoma Immunotherapy by Drug Induced Expression of Tumor-Specific Cryptic Neoantigens |
University of Minnesota / David Largaespada, PhD |
Innovation Grants |
2016 |
Minnesota |
Circulating Exosomes as Biomarkers of Medulloblastoma Progression, Metastasis, and Recurrence |
Weill Cornell Medical College / David Lyden, MD/PhD & Parveen Raju, MD/PhD |
Innovation Grants |
2016 |
New York |
Targeted Inhibition of Lin28/let-7 Binding to Treat Pediatric Malignancy |
Boston Children’s Hospital / George Q. Daley, MD/PhD |
Innovation Grants |
2016 |
Massachusetts |
CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL |
Children’s Hospital of Philadelphia / Asen Bagashev, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma |
National Cancer Institute / Marielle Yohe, MD/PhD |
Young Investigator Grants |
2016 |
Maryland |
A CRISPRi Genetic Screen in Ewing sarcoma Identifies a Novel Dependence on Homologous Recombination DNA Repair |
University of California San Francisco / Asmin Tulpule, MD/PhD |
Young Investigator Grants |
2016 |
California |
The Role of ARID1A in Neuroblastoma Pathogenesis |
Dana-Farber Cancer Institute / Hui Shi, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
Pre-clinical Evaluation of LSD1 Inhibitors for the Treatment of Pediatric Ewing sarcoma: Defining the Biomarkers of Sensitivity and Mechanisms of Resistance |
Research Institute at Nationwide Children's Hospital / Kathleen Pishas, PhD |
Young Investigator Grants |
2016 |
Ohio |
Genetically Engineered T Cells as Therapy for Pediatric Glioma |
Baylor College of Medicine / Giedre Krenciute, PhD |
Young Investigator Grants |
2016 |
Texas |
Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma |
Dana-Farber Cancer Institute / David Debruyne, PhD |
Young Investigator Grants |
2016 |
Massachusetts |